GO:0036424 L-phosphoserine phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036424 defines L-phosphoserine phosphatase activity, the hydrolysis of O-phospho-L-serine to L-serine and phosphate on a free amino acid.
• The reaction is the terminal step of the phosphorylated L-serine biosynthesis pathway, which converts the glycolytic intermediate 3-phosphoglycerate into L-serine.
• Human phosphoserine phosphatase (PSPH) is a HAD-family enzyme whose open and closed conformations have been resolved crystallographically.
• Bacterial and insect orthologs such as SerB2 from Mycobacterium tuberculosis and Bombyx mori PSPH show conserved catalytic residues but distinct regulatory features.
• PSPH is induced by amyloid-beta (1-42) in rat models, linking the enzyme to neurodegeneration-related serine metabolism.
• Small-molecule inhibitors of phosphoserine phosphatase have been developed, providing chemical tools to probe pathway flux.
Description
L-phosphoserine phosphatase activity (GO:0036424) is a molecular function that catalyzes the final, irreversible step of the phosphorylated L-serine biosynthesis pathway: the hydrolysis of O-phospho-L-serine to L-serine and inorganic phosphate. This activity is essential because L-serine is a precursor for proteins, phospholipids, sphingolipids, nucleotides, and the neuromodulators glycine and D-serine. In humans, the enzyme responsible is PSPH (phosphoserine phosphatase), a member of the haloacid dehalogenase (HAD) superfamily, whose crystal structure in the open conformation has been determined at high resolution. The reaction is metal-dependent and proceeds through a phosphoenzyme intermediate, a catalytic strategy shared with other HAD phosphatases. Because L-serine availability influences cell proliferation, neurodevelopment, and redox balance, L-phosphoserine phosphatase activity is a focal point for cancer metabolism, neuroscience, and antimicrobial drug discovery. Researchers study this activity using enzyme kinetics, structural biology, and CRISPR-based genetic models to dissect its role in health and disease.
L-phosphoserine phosphatase activity At A Glance
| GO ID | GO:0036424 |
|---|---|
| GO term | L-phosphoserine phosphatase activity |
| Ontology | molecular_function |
| Synonym | O-phosphoserine phosphohydrolase activity; phosphoserine phosphatase activity |
| Definition | Catalysis of the reaction: O-phospho-L-serine + H2O = L-serine + phosphate, on a free amino acid. |
| Major function | Terminal step of L-serine biosynthesis from phosphorylated intermediates |
| Enzyme family | Haloacid dehalogenase (HAD) superfamily, type II phosphatases |
| Cofactor | Divalent metal ion (Mg2+ or Mn2+) required for activity |
| Subcellular location | Cytoplasm (human PSPH) |
What Is GO:0036424?
In simple terms, L-phosphoserine phosphatase activity is the enzyme function that removes a phosphate group from O-phospho-L-serine, releasing free L-serine and phosphate. According to the QuickGO definition, it catalyzes the reaction O-phospho-L-serine + H2O = L-serine + phosphate, acting on a free amino acid. This activity is synonymous with O-phosphoserine phosphohydrolase activity and phosphoserine phosphatase activity. It is a molecular function (GO:0036424) that belongs to the HAD-like hydrolase family and requires a divalent metal ion for catalysis.
Why Is L-phosphoserine phosphatase activity Important in Cell Biology?
L-phosphoserine phosphatase activity is important because it gates the production of L-serine, a non-essential amino acid that becomes conditionally essential during rapid cell growth and in the brain. The enzyme is the last step in a three-enzyme pathway that also includes D-3-phosphoglycerate dehydrogenase and phosphoserine aminotransferase, and its activity determines the flux of glycolytic carbon into serine. In neurons, L-serine is the precursor of D-serine and glycine, both of which modulate NMDA receptor signaling. In pathogens such as Mycobacterium tuberculosis, the serine biosynthesis pathway, including SerB2, is essential for survival and is a validated drug target. Consequently, understanding L-phosphoserine phosphatase activity has implications for cancer therapy, neuropsychiatric disorders, and infectious disease.
• Provides L-serine for protein synthesis, nucleotide synthesis, and one-carbon metabolism.
• Supplies the precursor for D-serine and glycine, key neuromodulators of NMDA receptors.
• Supports cancer cell proliferation by maintaining serine flux under metabolic stress.
• Is essential for Mycobacterium tuberculosis survival, making it an antibacterial target.
• Its inhibition by small molecules can modulate serine levels in cells.
• Links to neurodegeneration because amyloid-beta induces PSPH in rat brain.
• Structural studies reveal conformational changes that can be exploited for drug design.
• Insect orthologs like Bombyx mori PSPH inform comparative serine metabolism.
• The enzyme is a model for HAD-family phosphatase mechanism and metal catalysis.
• CRISPR knockout of PSPH can reveal serine auxotrophy in specific cell types.
What Happens During L-phosphoserine phosphatase activity?
Substrate binding and conformational change
In simple terms: The enzyme grabs the phosphate-carrying serine molecule and changes shape to hold it tightly.
Human phosphoserine phosphatase (PSPH) binds O-phospho-L-serine in an open conformation that closes upon substrate binding, as shown by high-resolution crystal structures. The substrate's phosphate group coordinates with the active-site metal ion and conserved residues, positioning the serine moiety for hydrolysis. This induced-fit mechanism ensures specificity for the free amino acid substrate.
Phosphoenzyme intermediate formation
In simple terms: The enzyme temporarily takes the phosphate group onto itself.
Catalysis proceeds through a phosphoenzyme intermediate, a hallmark of HAD-family phosphatases. A conserved aspartate residue attacks the phosphorus atom of O-phospho-L-serine, releasing L-serine and forming a covalent phospho-aspartate intermediate. This step requires a divalent metal ion, typically Mg2+, which stabilizes the transition state.
Hydrolysis and product release
In simple terms: Water breaks the enzyme-phosphate bond, freeing phosphate and resetting the enzyme.
In the second half of the reaction, a water molecule hydrolyzes the phospho-aspartate intermediate, releasing inorganic phosphate and regenerating the free enzyme. The active site then opens to release phosphate and allow binding of the next substrate molecule. This two-step mechanism is conserved in bacterial SerB2 and other HAD phosphatases.
Pathway context and metabolic role
In simple terms: This enzyme is the last step in making serine from a glycolysis intermediate.
L-phosphoserine phosphatase activity completes the phosphorylated L-serine biosynthesis pathway, which starts with D-3-phosphoglycerate dehydrogenase converting 3-phosphoglycerate to 3-phosphohydroxypyruvate, followed by transamination to O-phospho-L-serine, and finally dephosphorylation by PSPH. This pathway is a major source of L-serine in tissues with low dietary serine intake, including the brain. In Mycobacterium tuberculosis, the SerB2 enzyme performs the same reaction and is essential for growth.
Key Genes Involved in GO:0036424 L-phosphoserine phosphatase activity
The following genes and proteins are directly associated with L-phosphoserine phosphatase activity or its metabolic pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSPH | Human L-phosphoserine phosphatase; catalyzes terminal step of serine biosynthesis | Target for cancer metabolism and neurobiology; crystal structure available |
| PHGDH | D-3-phosphoglycerate dehydrogenase; first step of phosphorylated serine pathway | Oncogene in breast cancer and melanoma; links to serine flux |
| PSAT1 | Phosphoserine aminotransferase; second step converting 3-phosphohydroxypyruvate to O-phospho-L-serine | Associated with cancer proliferation and serine auxotrophy |
| SHMT1 | Serine hydroxymethyltransferase 1; interconverts serine and glycine | One-carbon metabolism and nucleotide synthesis |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase; supports glycine production | Target in cancer and mitochondrial metabolism |
| MTHFD2 | Methylenetetrahydrofolate dehydrogenase 2; one-carbon cycle | Linked to serine-dependent cancer growth |
| SerB2 | Mycobacterium tuberculosis phosphoserine phosphatase; HAD-family enzyme | Essential for bacterial survival; drug target |
| BmPSPH | Bombyx mori phosphoserine phosphatase; silkworm serine synthesis | Insect model for serine metabolism |
| HADH | Haloacid dehalogenase-like hydrolase domain-containing protein; related family member | Structural and mechanistic comparisons |
| PSPHL | Putative phosphoserine phosphatase-like protein | Potential pseudogene or paralog; less characterized |
| PGAM1 | Phosphoglycerate mutase 1; glycolytic enzyme upstream of serine synthesis | Indirectly affects serine pathway flux |
| PKM | Pyruvate kinase M; controls glycolytic carbon entry into serine synthesis | Metabolic context for PSPH activity |
| ATF4 | Activating transcription factor 4; regulates serine synthesis genes under stress | Transcriptional regulation of PSPH and pathway |
| mTOR | Mechanistic target of rapamycin; promotes serine synthesis via ATF4 | Signaling regulator of PSPH expression |
| c-Myc | Oncogenic transcription factor; drives serine synthesis genes | Links PSPH pathway to cancer |
| p53 | Tumor suppressor; modulates serine metabolism | Context-dependent regulation of PSPH |
| Nrf2 | Oxidative stress transcription factor; influences serine synthesis | Redox regulation of PSPH pathway |
How Is L-phosphoserine phosphatase activity Regulated?
L-phosphoserine phosphatase activity is regulated at multiple levels. Transcriptionally, the PSPH gene is induced by ATF4 downstream of mTOR signaling and amino acid stress, linking serine synthesis to nutrient availability. In rat neurons, amyloid-beta (1-42) induces L-phosphoserine phosphatase, an effect inhibited by interleukin-11, suggesting cytokine-mediated regulation in neuroinflammation. Post-translationally, the enzyme requires a divalent metal ion for activity, and its catalytic cycle involves a phosphoenzyme intermediate that can be modulated by small-molecule inhibitors. In Mycobacterium tuberculosis, SerB2 activity is regulated by its oligomeric state and metal occupancy. These layers of regulation allow cells to adjust L-serine production to metabolic demand.
L-phosphoserine phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSPH | Cancer cell proliferation; serine auxotrophy | CRISPR knockout in cancer cell lines; rescue with L-serine |
| PSPH | Alzheimer's disease; amyloid-beta-induced neurotoxicity | Primary rat neurons treated with amyloid-beta; PSPH knockdown |
| SerB2 | Tuberculosis; bacterial survival | Mycobacterium tuberculosis SerB2 knockout; growth assays |
| PHGDH | Breast cancer and melanoma; serine synthesis | CRISPR knockout or overexpression in tumor models |
| PSAT1 | Cancer metabolism; serine pathway flux | Point mutation of catalytic residues; metabolic profiling |
Cancer metabolism
Many cancer cells depend on de novo serine synthesis for proliferation, and PSPH is part of this pathway. Upregulation of the phosphorylated serine pathway, including PHGDH and PSAT1, is observed in breast cancer, melanoma, and other tumors. Inhibiting L-phosphoserine phosphatase activity could reduce serine availability and impair tumor growth, making it a potential therapeutic target.
Neurodegeneration and neuroinflammation
In rat models, amyloid-beta (1-42) induces L-phosphoserine phosphatase, and this induction is blocked by interleukin-11. Because L-serine is a precursor of D-serine and glycine, dysregulation of PSPH may contribute to NMDA receptor dysfunction in Alzheimer's disease and related disorders. The enzyme thus links amyloid pathology to altered serine metabolism in the brain.
Tuberculosis and infectious disease
Mycobacterium tuberculosis SerB2 is an essential HAD-family phosphatase that catalyzes L-phosphoserine phosphatase activity. Deletion or inhibition of SerB2 impairs bacterial growth, validating the enzyme as an antibacterial target. Structural and mechanistic studies of SerB2 provide a basis for designing specific inhibitors.
From L-phosphoserine phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PSPH cause serine auxotrophy? | CRISPR knockout of PSPH in cell lines; serine-free medium |
| What is the catalytic role of a specific residue? | Point mutation of active-site aspartate; enzyme kinetics |
| Can a tagged PSPH rescue knockout phenotypes? | Knock-in of FLAG- or GFP-tagged PSPH; imaging and immunoprecipitation |
| Does overexpression of PSPH increase serine flux? | Overexpression of PSPH in cancer cells; metabolomics |
| Is SerB2 essential in Mycobacterium tuberculosis? | CRISPR interference or conditional knockout in M. tuberculosis |
| How does amyloid-beta regulate PSPH? | Knockdown or knockout of PSPH in neurons; amyloid-beta treatment |
How to Study the L-phosphoserine phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphatase assay | Release of phosphate or L-serine | Enzyme kinetics and inhibitor testing |
| X-ray crystallography | Three-dimensional structure of PSPH | Active-site mapping and drug design |
| CRISPR knockout | Loss-of-function phenotype | Serine auxotrophy and proliferation assays |
| Metabolomics | Levels of serine and pathway intermediates | Metabolic profiling of PSPH mutants |
| Stable isotope tracing | Flux through serine synthesis | Quantifying pathway activity |
| Western blot | Protein expression of PSPH | Validation of knockout or overexpression |
| qRT-PCR | mRNA levels of PSPH | Transcriptional regulation studies |
| Immunofluorescence | Subcellular localization of PSPH | Cytoplasmic distribution and trafficking |
Enzyme kinetics and phosphatase assays
L-phosphoserine phosphatase activity can be measured using colorimetric or fluorometric assays that detect released phosphate or L-serine. Purified recombinant PSPH or cell lysates are incubated with O-phospho-L-serine, and the reaction is monitored spectrophotometrically. These assays are used to determine kinetic parameters and to test inhibitors.
Structural biology (X-ray crystallography and cryo-EM)
High-resolution crystal structures of human PSPH in open and closed conformations have revealed the active-site architecture and conformational changes during catalysis. Bacterial SerB2 structures provide additional insights into HAD-family mechanism. These methods guide rational drug design.
CRISPR-based genetic screens and knockout models
CRISPR knockout of PSPH or pathway genes can be used to assess serine dependence in cancer cell lines. Pooled CRISPR screens with serine-free media can identify genes that become essential when L-phosphoserine phosphatase activity is lost. These approaches link genotype to metabolic phenotype.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics quantifies L-serine, glycine, and pathway intermediates in cells with altered PSPH activity. Stable isotope tracing with 13C-glucose or 13C-serine measures flux through the phosphorylated serine pathway. These methods reveal how PSPH contributes to central carbon metabolism.
How CRISPR Can Be Used to Study GO:0036424 L-phosphoserine phosphatase activity
Knockout
CRISPR knockout of PSPH generates cell lines completely lacking L-phosphoserine phosphatase activity, enabling studies of serine auxotrophy and metabolic rewiring. These models are valuable for testing whether cancer cells depend on de novo serine synthesis. Knockout of bacterial SerB2 can also validate essentiality in Mycobacterium tuberculosis.
Point Mutation
Point mutations in the PSPH active site, such as substitution of the catalytic aspartate, can abolish L-phosphoserine phosphatase activity while preserving protein structure. Such mutants are used to dissect the phosphoenzyme intermediate mechanism and to test substrate specificity. They also serve as negative controls in rescue experiments.
Knock-in
Knock-in of epitope-tagged PSPH (e.g., FLAG or GFP) allows visualization and immunoprecipitation of the endogenous enzyme. Tagged knock-in models can be used to study PSPH localization, interaction partners, and turnover in live cells. This approach avoids artifacts from overexpression.
Overexpression
Overexpression of wild-type PSPH increases L-phosphoserine phosphatase activity and can elevate L-serine levels, promoting proliferation under serine-limited conditions. Overexpression models are useful for testing whether increased serine synthesis drives tumor growth. They also help identify downstream metabolic effects.
How EDITGENE Supports L-phosphoserine phosphatase activity Research
Researchers studying L-phosphoserine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in serine metabolism, cell proliferation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of PSPH and its pathway partners.
Contact EDITGENE today to design your custom CRISPR model for L-phosphoserine phosphatase activity research.
Frequently Asked Questions About L-phosphoserine phosphatase activity
What is L-phosphoserine phosphatase activity?
L-phosphoserine phosphatase activity (GO:0036424) is the enzyme function that catalyzes the hydrolysis of O-phospho-L-serine to L-serine and phosphate, the final step in the phosphorylated L-serine biosynthesis pathway.
What genes are involved in L-phosphoserine phosphatase activity?
The primary gene is PSPH, which encodes human phosphoserine phosphatase. Pathway partners include PHGDH and PSAT1, and bacterial orthologs include SerB2.
What is the reaction catalyzed by L-phosphoserine phosphatase?
The reaction is O-phospho-L-serine + H2O = L-serine + phosphate, acting on a free amino acid.
Where is L-phosphoserine phosphatase located in the cell?
Human PSPH is a cytoplasmic enzyme, as shown by subcellular fractionation and immunofluorescence studies.
What diseases are linked to L-phosphoserine phosphatase activity?
It has been linked to cancer metabolism, Alzheimer's disease via amyloid-beta induction, and tuberculosis through essential SerB2.
How is L-phosphoserine phosphatase activity regulated?
It is regulated transcriptionally by ATF4 and mTOR signaling, and post-translationally by metal ion availability and small-molecule inhibitors.
What is the mechanism of L-phosphoserine phosphatase?
It uses a two-step mechanism involving a phosphoenzyme intermediate and a divalent metal ion, typical of HAD-family phosphatases.
Can L-phosphoserine phosphatase be inhibited?
Yes, novel inhibitors of phosphoserine phosphatase have been developed and characterized, providing chemical tools for research.
What model systems are used to study L-phosphoserine phosphatase activity?
Common models include human cancer cell lines, rat neurons, Mycobacterium tuberculosis, and silkworm (Bombyx mori).
Why is L-phosphoserine phosphatase important for cancer?
Many cancer cells rely on de novo serine synthesis, and PSPH supports this pathway; its inhibition may impair tumor growth.
Conclusion
L-phosphoserine phosphatase activity (GO:0036424) is a critical enzymatic function that completes the phosphorylated L-serine biosynthesis pathway, supplying serine for protein synthesis, one-carbon metabolism, and neurotransmission. Its structural and mechanistic features are well characterized, and its links to cancer, neurodegeneration, and infectious disease make it a compelling target for further study. CRISPR-based models offer powerful tools to dissect its role in health and disease.
References
- 1. Grant GA. 2018. D-3-Phosphoglycerate Dehydrogenase.. Front Mol Biosci 5:110 PMID: 30619878
- 2. Haque MR et al.. 2020. Molecular survey of the phosphoserine phosphatase involved in L-serine synthesis by silkworms (Bombyx mori).. Insect Mol Biol 29(1):48-55 PMID: 31294881
- 3. Hawkinson JE et al.. 1997. Novel phosphoserine phosphatase inhibitors.. Eur J Pharmacol 337(2-3):315-24 PMID: 9430431
- 5. Heese K et al.. 2000. Induction of rat L-phosphoserine phosphatase by amyloid-beta (1-42) is inhibited by interleukin-11.. Neurosci Lett 288(1):37-40 PMID: 10869810
- 7. Peeraer Y et al.. 2003. High-resolution structure of human phosphoserine phosphatase in open conformation.. Acta Crystallogr D Biol Crystallogr 59(Pt 6):971-7 PMID: 12777757
- 8. Yadav GP et al.. 2014. Characterization of M. tuberculosis SerB2, an essential HAD-family phosphatase, reveals novel properties.. PLoS One 9(12):e115409 PMID: 25521849
